Paul Vaillant-Couturier, F-94807 Villejuif Cedex, France; laurent.orsi{at}inserm.fr Objectives Investigating the role of occupational exposure to solvents in the occurrence of lymphoid neoplasms (LNs) ...

In this review, we aim to provide a comprehensive summary of the existing classifications for TLS maturity and therapeutic strategies capable of inducing its formation in tumors. The formation of TLS ...

TNFR2 expression is restricted to certain tumor cells and subpopulations of the lymphoid system, especially immunosuppressive cells ... will significantly improve the therapeutic effect remains to be ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

AtLP are conditions in which it is not possible to differentiate between the benign and the malignant nature of a given lymphoid infiltrate. The descriptive term AtLP may be used as an interim ...

and mechanistic insights reveal pathways to improved functionality of CAR T cells in solid tumors. In December 2024, the NIH Office of Autoimmune Disease Research in the Office of Research on ...

While some types of cancer can be treated successfully, they may relapse, meaning a complete cure for cancer is not always ...

9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T ... Molecular Zip Code Draws Killer T ...

Oncomine World is back with brand NEW features Now in its sixth year, OncomineWorld meetings have united thousands of scientists and professionals from around the globe to advance genomic pr ...